FMT is a promising form of treatment and has been proven effective against C. difficile infection. However, fecal transplant is fairly new and more studies need to be made to make this procedure less risky.
The biggest risk of fecal transplantation is the potential transmission of pathogenic bacteria that may cause more harm to the patient.
Recently, the FDA issued a warning against the use of fecal transplants, which prompted the improvement in the screening of fecal donors.
Fecal transplant can be compared to blood transfusion where there’s a chance of acquiring harmful bacteria and viruses from the donor if the specimen is not screened and examined carefully.
Poop transplants save lives and as technology improves and more research is being conducted, screening for donors has become safer and will continue to improve in the succeeding years.
How It’s Done
FMT is commonly delivered via a colonoscopy, poop pills, or through the nose (Nasoenteric tube). The method of delivery depends on the condition of the patient and the assessment of the healthcare provider. As a whole, the FMT procedure is quite safe. Poop transplants save lives.
The treatment may cause mild discomforts such as mild bloating, gas, and low-grade fevers. But other than that, there are no adverse effects to FMT treatment.
Routine laboratory tests are performed on the donor’s blood and an in-depth medical history is gathered, as well as screening for microbial organisms in the donor’s stool.
The donor should not have consumed antibiotics for the past two to three days. Blood and stool samples will be examined for signs of infection.
Treatment for Other Diseases
More studies are being conducted to prove that poop transplants save lives. In addition to treating CDI, FMT may help treat other conditions as well.